Introduction
Bipolar disorder is a severe mental disorder characterized by recurrent manic and depressive episodes. Twin, adoption, family and linkage studies suggested that bipolar disorder is a complex disease caused by multiple genetic and environmental risk factors. 1 Pharmacological evidence suggests the involvement of monoaminergic systems and intracellular second messenger systems in bipolar disorder. 2, 3 However, the etiology of bipolar disorder has not been established. The uncertainty of phenotype definition and complex mode of inheritance impede the understanding of bipolar disorder at the molecular level by conventional strategies.
Genome-wide gene expression analysis using DNA microarray, by which expression of thousands of genes can be monitored, has a great advantage to identify the genes or specific molecular cascades involved in the complex diseases, especially mental disorders. 4 Pioneering studies, which examined the postmortem brains of patients with schizophrenia by DNA microarray, revealed the downregulation of the genes encoding proteins functioning at the presynapses, 5 genes expressed in the oligodendrocytes, 6 neuropeptide Y, 7 or the upregulation of apolipoprotein genes in schizophrenia. 8 On the other hand, there is one DNA microarray study of bipolar disorder, which revealed the altered expression of the genes encoding the signal transduction proteins. 9 Bipolar disorder shares signs and symptoms of depressive episodes with major depression, and also shares clinical features with schizophrenia, such as their chronic and relapsing course, and psychotic symptoms. 10 The molecular basis of the uniqueness of bipolar disorder and its similarity to the other two disorders remains to be studied. Here, we carried out the microarray analysis in bipolar disorder, major depression, schizophrenia, and control subjects using postmortem frontal cortices provided by the Stanley Foundation Brain Collection. The differentially expressed genes in bipolar disorder were compared with those in other mental disorders.
Among the genes whose differential expressions in the brains were confirmed by RT-PCR, the expressions of LIM and HSPF1 were also altered in lymphoblastoid cells of patients with bipolar disorder. These genes may have some pathophysio-logical importance such as the genetic abnormality in bipolar disorder.
Materials and methods

Brain samples
Samples of postmortem prefrontal cortex (Broadmann's Area 10) were donated by the Stanley Foundation Brain Collection. They were derived from patients with bipolar disorder, major depression, schizophrenia, and control subjects. Each group consisted of 15 subjects. Diagnoses had been made according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. 11 A summary of the demographic information of subjects used in this study is shown in Table 1 . Detailed information of the original set of subjects was described elsewhere. 12 
Microarray procedure
Total RNA was extracted from 0.1 g of frozen tissues using Trizol (Invitrogen, Groningen, The Netherlands). After cleaning up using an RNeasy column (Qiagen, Hilden, Germany), the purity and integrity of total RNA was evaluated by OD measurements and denaturing agarose gel electrophoresis, respectively. Microarray analysis was performed according to the manufacturer's protocol (Affymetrix, Santa Clara, CA, USA). Briefly, 8-10 mg of total RNA was used to synthesize cDNA. This was used to generate biotinylated cRNA. cRNA was fragmented and first applied Beta actin  152  ATTGCCGACAGGATGCAGAA  TTGCTGATCCACATCTGCTGG  Cofilin  73  CGCCCCTTAAGAGCAAAATG  TGCAATTCATGCTTGATCCC   HSP27  113  GTCCCTGGATGTCAACCACTTC  AGATGTAGCCATGCTCGTCCTG  IFITM3  90  TCGTCTGGTCCCTGTTCAACA  TCCTGTCCCTAGACTTCACGGA  CEBPD  101  CATCGACTTCAGCGCCTACAT  CCTTGTGATTGCTGTTGAAGAGGT  APM2  96  TGACGACTCCACAGATACCCC  GCTGACACGGCTTCCTGG  AQP4  144  TGTCTTCTACATCGCAGCCCA  TCAACCAGGAGACCATGACCA  HEPH  237  AGGAAAATGTGGCAACCCATG  TCTCGCCATTCCGATAGAGGA  LIM  111  TCCTTGGAGAAGTCATCAATGC  CACCATCCTCCAAGTGAAAAAC  KIAA0133  137  AGTATGGAAGCGTCTTCCCGA  CCCTTCCCGCATAACTGAAAA  CACNA1A  90  ACCTCAGTACCATCTCAGACACCAG  CCAGCGAGTAATCGTCCAGG  GRM1  99  TCTGTGAAGGCATGACAGTGCG  TGTCTGCCCATCCATCACTTC  GRIK1  86  GGCGGTTAGAGATGGATCAACA  TGCTGCTCATGAAAGCCCA  DTNA  134  TGTCTTCCATCCGGTTGAGTG  TATGAGAACCACCGGCATGTC  HSP40  139  TGATGTCATTTATCCTGCCAGG  AGGAACTTTTCGCCGCATG  DKFZp564H203  84  GCAGACAGAAAACCTCAACCCC  AACAAGCACTTCCTGTGCCCAG  COL16A1  89  GACATTGGTATTGGCATTGCAG  GTTGCACCCATCTTGCCAT  SPRAC  113  AATGACAAGTACATCGCCCTGG  GAGAATCCGGTACTGTGGAAGG  BTN3A3  144  TACGCTGCAACAGAGCAAGAA  CACATCCGCAGGTTTGAAGA  TAF6L  81  GGACTTGCAGACGAACTCCAA  TGGCTTACAGATTTCACCCCA  GOLGA4  128  GGACACCTTACAAAGGTGGCAA  TGCCATGGTCTTAGTCTCACGA  KIAA0645  154  GACCCTGGATGTTGACGTGAA  CAACCTTGGACCATCTCGAAG  KDR  94  AGAGCCGGCCTGTGAGTGTAAA  CCACTGTCCGTCTGGTTGTCAT to the Test2Chip (Affymetrix) to assess the sample quality, and then applied to the HU95A chip (Affymetrix), which contains probes for about 12 000 genes. The hybridization signal on the chip was scanned using a scanner (HP GeneArray scanner, Hewlett-Packard, Palo Alto, CA, USA), and was processed by GeneSuite software (Affymetrix).
Microarray data analysis
The gene expression data generated by microarray analysis were imported into GeneSpring 5. 
Lymphoblastoid cells
Lymphoblastoid cell lines of control subjects and patients with bipolar disorder were established by standard protocols. 13 A summary of demographic information of subjects is shown in Table 1 . Briefly, lymphocytes were separated from peripheral blood using Ficoll-Paque (Pharmacia-Upjohn, Peapack, NJ, USA), and cultured with RPMI 1640 medium containing 20% fetal bovine serum (FBS), penicillin, streptomycin, cyclosporin A, and filtered supernatant of the B95-8 cell culture infected by Epstein-Barr Virus. The cells were subcultured every week until the cell line was established. Thereafter, the cells were subcultured three times a week using a similar medium, except for the addition of 10% FBS and no cyclosporin A. The cells were kept frozen until the experiment. After reculturing, total RNA of the cells was extracted using Trizol reagent and then was treated with DNase I. This study was approved by the Ethical Committee of the Brain Science Institute, RIKEN, and written informed consent was obtained from each subject.
Real-time quantitative PCR
A measure of 1-5 mg of total RNA was used for cDNA synthesis by oligo(dT) and SuperScript II reverse transcriptase (Invitrogen). Real-time quantitative PCR using SYBR/GREEN I dye (Applied Biosystems, Foster City, CA, USA) was performed with ABI PRISM 7700 or 7900HT (Applied Biosystems). The comparative Ct method was employed for quantification of transcripts according to the manufacturer's protocol (User Bulletin #2, Applied Biosystems). In addition to the two housekeeping genes conventionally used for normalization (beta actin and GAPDH), cofilin 1, which encodes actin-binding protein, was selected as a control gene by identifying a gene showing the constant expression levels by DNA microarray analysis across the samples (data not shown). Measurement of delta Ct was performed at least in triplicate. Amplification of the single product in RT-PCR was confirmed by monitoring the dissociation curve and by agarose gel electrophoresis. Onetailed and two-tailed Student's t-tests were employed in the statistical analysis of the results of postmortem brains and lymphoblastoid cells, respectively (Po0.05 was considered to be significant). The genes examined by RT-PCR were as follows: HSP27, IFITM3, CEBPD, APM2, AQP4, HEPH, LIM, KIAA0133, CACNA1A, GRM1, GRIK1, DTNA, HSPF1, DKFZp564H203, COL16A1, SPARC, BTN3A3, TAF6L, GOLGA4, KIAA0645, and KDR. They were chosen for the quantitative PCR analysis, since they were also identified as the differentially expressed genes by the preliminary data analysis based on different normalization procedures (data not shown). Primer sequences used for RT-PCR are listed in Table 2 .
Results and discussion
Filtering procedures
Of the 60 samples initially analyzed, 10 were not suitable for DNA microarray analysis estimated by denaturing agarose gel electrophoresis or Test2Chip analysis. Thus, we could obtain gene expression profiles from 50 samples. These included 11 patients with bipolar disorder, 11 with major depression, 13 with schizophrenia, and 15 control subjects. Although there were no significant differences in the demographic variables among four groups, we removed the genes whose expressions were associated with aging, gender or postmortem interval (PMI). The genes previously reported to be altered with aging were confirmed, such as aging-dependent upregulation of cathepsin D and downregulation of collagen, type XI (Figure 1a) . 14 The genes influenced by gender mainly consisted of the genes on the sex chromosomes (Figure 1b) , including three nonrecombining region of the Y chromosome (NRY) class I genes. X homologues of NRY class I genes were also highly expressed in females, which is compatible with the finding that they are not subject to X inactivation in females. 15 These results imply the reliability of our microarray analysis. Although these genes might offer some insight into the significance of the pathophysiology, they were eliminated from the analysis since the sample size was not large enough to be subject to subgroup analysis.
Among the previously reported DNA microarray studies of mental disorders, Hakak et al reported the differentially expressed genes in schizophrenia, using a microarray system comparable with ours. 6 Comparison of the microarray results by the clustering analysis revealed that schizophrenics could be rela- tively well separated from control subjects, despite independent samples being used (Figure 4 ). In addition, the reduced expression of neuropeptide Y in schizophrenia 7 was also observed in this study (data not shown). These would suggest the consistency and reproducibility of the microarray analyses using postmortem samples performed by independent studies.
Gene expression changes in bipolar disorder
The scatterplot drawn based on the genes after the filtering procedures showed that the gene expressions of most of the genes were similar between bipolar disorder and control groups from high to low expression levels (Figure 2) . We defined the differentially expressed genes based on the fold change (1.3-fold or greater) and the P-value (Po0.05) of the mean expression values. The number of genes that met our criteria was 53. As expected, the hierarchical clustering analysis based on the expression level of these genes could separate patients well from control subjects (Figure 3a) . Importantly, some of the genes encoding channels, receptors, or transporters were downregulated, suggesting the impairment of the diverse neuronal functions within the prefrontal cortex in patients with bipolar disorder, similar to the results of microarray studies of schizophrenia. 5, 6 On the other hand, genes encoding the stress response proteins or molecular chaperones, whose expressions were usually induced by environmental insult, were upregulated in bipolar disorder (Figure 3c ). Several lines of evidence suggest their neuroprotective roles by preventing the formation of protein aggregations 16 or the neuronal cell death induced by injury. 17 Their altered expressions might be involved in part of the pathophysiology of bipolar disorder.
Many lines of evidence suggest that the dysregulation of calcium-dependent signal transductions are involved in bipolar disorder. 18 The downregulation of channels or receptors, CACN1A, HTR2C, GRM1, GRIK1, and the upregulation of LIM would directly affect the intracellular calcium ion concentration. The glutamatergic system is the main excitatory neurotransmitter system responsible for fundamental brain functions, and hypofunction of this system has been postulated in schizophrenia 19 and bipolar disorder. 20 The downregulation of two glutamate receptors, GRIK1 and GRM1, would be involved in the hypofunction of this system in bipolar disorder. In addition to GRIK1, HTR2C and NOTCH4 have been the candidate genes for association studies of schizophrenia and bipolar disorder, although consistent results have not been obtained. [21] [22] [23] [24] [25] [26] [27] [28] It may be interesting to note the upregulation of dystrobrevin alpha gene, DTNA, in bipolar disorder, since genetic variation of DTNBP1 (dystrobrevin-binding protein 1) was recently reported to be associated with schizophrenia. 29, 30 DTNA and DTNBP1 are the components of dystrophin-associated protein complex (DPC), 31 and the altered function of DPC may cause the dysregulation of maturation and maintenance of the synapses.
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Uniqueness of bipolar disorder and its similarity to major depression and schizophrenia at the molecular level We compared the differentially expressed genes in bipolar disorder with those in major depression and schizophrenia (Figure 3b) . The hierarchical clustering analysis revealed that the differentially expressed genes identified in major depression and schizophrenia were useful for the separation of patients from control subjects (Figure 4b ), suggesting the appropriateness of data analysis in major depression and schizophrenia. Interestingly, most of the differentially expressed genes in bipolar disorder, as mentioned above, were not shared with these two diseases, suggesting that they are distinctive diseases at the molecular level. Unexpectedly, despite bipolar disorder and major depression sharing symptomatic similarities and genetic background, these were clearly different with regard to gene expression patterns. Most of the genes showing altered expressions in two or more disorders turned out to encode the proteins responsible for transcription or translation (Figure 3c ). This finding may imply that the common pathophysiological background underlies the different mental disorders to some extent. Among the not many commonly altered gene expressions in bipolar disorder and the other two mental disorders, altered expression of AQP4, HTR2C, and LIM would be of particular interest. AQP4 is associated with DPC by interacting syntrophin, a component of DPC, 33 and is involved in the water permeability across the blood-brain barrier and cerebrospinal fluid-brain interface. 34 Impaired water homeostasis due to the upregulation of AQP4 could be involved in the pathophysiology common to bipolar disorder and depression such as white matter hyperintensity observed by magnetic resonance imaging, 35 although the effects of medication could not be excluded.
Considering the wide-ranging physiological roles of serotonin including regulation of mood, appetite, and sexual behavior, and the mechanisms of drugs such as the antipsychotic properties of serotonin-dopamine antagonists, and the hallucinogenic effects of serotonin agonists, 36 downregulation of HTR2C would contribute to the pathophysiology of common clinical features of bipolar disorder and schizophrenia such as psychotic symptoms.
LIM protein, initially identified as a protein kinase C (PKC)-beta-1-binding protein, 37 was recently found to regulate the N-type calcium channel activity by c Among the 21 genes tested, genes whose differential expressions were confirmed by three different control genes are shown. nd, RT-PCR product was not detected in the lymphoblastoid cells.
interacting with both calcium channel and PKC. 38 Considering that PKC activity is altered in bipolar disorder, and antibipolar drugs such as lithium and valproate regulate the PKC signaling cascade, 3, 18 upregulation of LIM may be involved in the pathophysiology of bipolar disorder, and may also be related to the common pathophysiology of major mental disorders.
Effects of medication status, alcohol abuse, and drug abuse on the gene expressions in bipolar disorder Among the 53 genes differentially expressed in bipolar disorder patients, the expressions of nine genes were significantly affected by anticonvulsants, antipsychotics, or drug abuse (Figure 3c ). No significant effects of lithium, antidepressants, and alcohol use were found. Since patients were usually treated with multiple drugs and had complex histories of medication status, alcohol, and drug abuse, the effects of these confounding factors on gene expressions are difficult to define. However, it would be interesting to note that two drug-free patients were clustered within one patient branch (Figure 3a ). This suggests that the altered gene expressions identified in this study largely reflect the pathophysiological conditions of bipolar disorder, rather than the effects of medication. More detailed studies will be needed to examine the effects of these factors as well as other confounding factors such as duration of illness and terminal condition of subjects.
Quantitative RT-PCR analysis
To consider the general consistency of microarray analysis, we compared the mRNA expression levels of each of the representative 21 genes measured by microarray and quantitative RT-PCR (see Materials and methods section). Although the correlations between the results by the two methods were highly variable and dependent on the gene tested, many of them were significantly correlated with each other (Table 3) . We then examined whether the differential expressions identified by microarray analysis were confirmed by RT-PCR. Among the 21 genes tested, the altered expressions in bipolar disorder were confirmed in 10 genes using three control genes for normalization (Table 4 ; Figure 5 ). This relatively low success rate of confirmation may be caused by multiple reasons such as strict criteria of quantitative RT-PCR analysis using three control genes, relatively small level of fold change in microarray analysis, and the type of genes we examined. In general, the downregulated genes encoding receptors or channels were difficult to obtain the consistency by quantitative RT-PCR analysis. This may be partly attributable to the complexity of their transcripts in the brain. 39 We also confirmed the gene expression changes observed in bipolar disorder and in other disorders; AQP4 in bipolar disorder and major depression, HSP27 in bipolar disorder and schizophrenia, LIM in three mental disorders (Figure 5b ). Table 4 for the P-values with respect to bipolar disorder. The P-values with respect to major depression are P ¼ 0.0156 (AQP4) and P ¼ 0.0150 (LIM), and those with respect to schizophrenia are P ¼ 0.0034 (HSP27) and P ¼ 0.018 (LIM). The P-value after excluding a subject with major depression showing extremely high-level expression of LIM (12.63) was still significant (P ¼ 0.0122).
Altered gene expressions in lymphoblastoid cells established from patients with bipolar disorder Lymphoblastoid cell lines are the only available tissue that can be cultured semipermanently from patients. Although lymphoblastoid cells have clear limitations in that they are unrelated to neuronal cells, they have advantages in that they are free from the effects of medication, and their altered gene expression may have some pathophysiological importance such as the genetic abnormality. We examined the mRNA expression levels of the 10 genes, whose differential expressions were confirmed by RT-PCR, in the lymphoblastoid cells (Table 4) . We could not detect the transcripts of the three genes, GRIK1, AQP4, and HEPH. Although no significant differences in the expression levels were found between bipolar disorder and control groups for most genes, HSPF1 and LIM showed the differential expressions in the lymphoblastoid cells (Table 4 ; Figure 6 ).
In contrast to the upregulation in the brain, the expression of LIM was downregulated in the lymphoblastoid cells of patients with bipolar disorder (Figures 5b and 6 ). The cause of these changes in the opposite directions remains unknown, but may be explained by the difference of tissue type. HSPF1 (HSP40) modulates the activity of HSP70 and direct unfolded proteins to HSP70, which leads to the translocation of proteins into the mitochondria and endoplasmic reticulum (ER). 40 Several recent studies delineated the altered function of mitochondria and ER in bipolar disorder. The altered levels of calcium ions, which were intracellularly stored in the mitochondria and ER, were reported in the lymphoblastoid cells in patients with bipolar disorder. 41, 42 In addition, the altered functions of ER were suggested by the increased levels of molecular chaperones in ER by valproate, and by the altered expression of molecular chaperons in the lymphoblastoid cells of patients with bipolar disorder (CK et al, in preparation). Considering the above findings, the altered expression of HSPF1 (Figures 5a and 6 ) could be involved in the aberration of protein translocation systems into the mitochondria and/or ER, which in turn affects the functions of these organelles.
Conclusion
In summary, we have performed microarray analysis of bipolar disorder using postmortem brains. By profiling the gene expression patterns of a large number of samples, we were able to remove possible effects of the confounding factors including aging, gender, and postmortem interval. By comparing the gene expression patterns of similar but different mental disorders, we identified the unique expression changes in bipolar disorder, and common expression changes between and among mental disorders. The genes identified in this study would be useful for the understanding of the pathophysiology of mental disorders, as well as the molecular genetic studies and drug development.
Since bipolar disorder as well as other psychiatric disorders are considered to be heterogeneous diseases, more detailed studies using a larger number of independent postmortem samples will be clearly needed to explore the gene expression differences among the possible subgroups of bipolar disorder. It is also not clear whether these gene expression changes in bipolar disorder are attributable to anatomical changes in brain such as glial loss or selective neuronal death. Histochemical analyses such as in situ hybridization, or single-cell transcript analysis 43 may be needed to address such question.
We successfully found the altered expression of two genes, LIM and HSPF1, in the lymphoblastoid cells established from patients with bipolar disorder. These findings will be needed to explore a larger number of samples and in the different ethnic groups. Even though it remains unclear whether the altered expressions of LIM and HSPF1 are caused by the genetic variations within these genes in patients, or by the secondary effects induced by other unidentified causes, these two genes would be novel candidate genes for bipolar disorder. . In each analysis, expression values were determined by using three different control genes. All the differences shown here are significant (two-tailed Student's t-test, Po0.05). See Table 4 for the P-values.
